Detalles de la búsqueda
1.
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.
Mov Disord;
38(3): 386-398, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807624
2.
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Ann Rheum Dis;
75(1): 196-202, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26038091
3.
A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma.
Respir Res;
17: 29, 2016 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26993628
4.
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.
Thorax;
70(8): 748-56, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26001563
5.
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.
Arthritis Rheum;
65(9): 2368-79, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23740801
6.
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study.
Arthritis Rheum;
64(11): 3666-76, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22833362
7.
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Arthritis Rheum;
64(4): 1215-26, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22231479
8.
Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma.
J Allergy Clin Immunol;
138(4): 1230-1233.e8, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27474124
9.
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.
Sci Transl Med;
14(648): eabj2658, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675433
10.
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10.
Sci Rep;
11(1): 12900, 2021 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34145320
11.
Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: A metabolomic study.
Neurology;
95(24): e3428-e3437, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32999056
12.
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs.
Clin Pharmacol Ther;
107(3): 553-562, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31544231
13.
Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial Injury.
Clin Pharmacol Ther;
105(1): 177-189, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29952004
14.
Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis.
J Clin Pharmacol;
56(6): 693-704, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26412221
15.
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE.
Lupus Sci Med;
2(1): e000080, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25861459
16.
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.
Sci Transl Med;
6(243): 243ra85, 2014 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24990880
17.
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Clin J Am Soc Nephrol;
8(1): 147-53, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22879439
Resultados
1 -
17
de 17
1
Próxima >
>>